01/15/2014: Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease
Massachusetts General Hospital, the Broad Institute, and Amgen announced today that they have launched a strategic collaboration to jointly discover and validate new therapeutic targets and develop novel therapies for inflammatory bowel disease, a chronic disorder that affects millions worldwide.
Kathleen Corey, MD, director of the Massachusetts General Hospital Fatty Liver Clinic and co-director of the Mass General Weight Center, discusses the connection between obesity and nonalcoholic fatty liver disease (NAFLD).
The Broad Institute and MGH are launching a new initiative to perform large-scale exome sequencing in inflammatory bowel disease.
07/16/2013: #1 in New England, #2 in the nation
U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.
06/07/2013: New procedure is easy to swallow
The MGH offers its first per-oral endoscopic myotomy (POEM) procedure, a new surgical treatment for achalasia.
MGH researchers have identified a gene variant that helps predict how much weight an individual will lose after gastric bypass surgery, a finding with the potential both to guide treatment planning and to facilitate the development of new therapeutic approaches to treating obesity and related conditions like diabetes.
Massachusetts General Hospital Weight Center surgeon Ozanan Meireles, MD, answers common questions about the effect of bariatric surgery on individuals with type 2 diabetes and prediabetes.
Thomas Gagnon arrived at Massachusetts General Hospital expecting to receive a kidney transplant. Instead, he was referred to the Mass General Weight Center for life-changing obesity treatment.
Changes in the microbial population of the gastrointestinal tract may underlie some of the benefits of gastric bypass surgery, reports a team of researchers from MGH and Harvard University. The investigators also found that post-bypass alterations in the microbial population of mice can induce weight loss in animals that did not have surgery.
Massachusetts General Hospital is partnering with the American Society of Colon and Rectal Surgeons, and Coaches vs. Cancer to promote screening and treatment for colorectal cancer.
A new capsule-like device may provide an alternative screening method for Barrett’s esophagus and esophageal cancer.
The New England Journal of Medicine publishes the three-year results of a study of the safety and effectiveness of a new device for treatment of gastroesophageal reflux disease (GERD).
Researchers at the Wellman Center for Photomedicine at Massachusetts General Hospital have developed an imaging system enclosed in a capsule about the size of a multivitamin pill that creates detailed, microscopic images of the esophageal wall.
The MGH was the first hospital in New England to offer a new procedure in which a flexible bracelet of magnetic titanium beads is laparoscopically implanted around the esophagus to help treat GERD.
12/24/2012: Innovations in Inflammatory Bowel Disease
Research at the Massachusetts General Hospital Digestive Healthcare Center, including clinical trials of new biologic medications, as well new minimally invasive surgical techniques, is helping expand treatment and management of patients with inflammatory bowel disease.
12/13/2012: Intestinal immune cells play an unexpected role in immune surveillance of the bloodstream
A type of immune cell found in the small intestine plays a previously unsuspected role in monitoring antigens circulating in the bloodstream. Disruption of the newly discovered regulatory system may lead to the development of autoimmune disorders, inflammatory bowel disease or food allergies.
09/24/2012: Frequently asked questions: LINX® system
David Rattner, MD, chief of the Division of Gastrointestinal and General Surgery at the Mass General Digestive Healthcare Center, answers frequently asked questions (FAQ) about the LINX® Reflux Management System, a new treatment option for gastroesophageal reflux disease (GERD).
08/23/2012: Weight loss surgery cuts diabetes risk
The results of a Swedish study show that weight loss surgery significantly reduces the risk of type 2 diabetes in obese people.
07/31/2012: MGH First & Only Hospital in New England to Offer LINX Procedure for Patients with Gastroesophageal Reflux Disease (GERD)
New, less invasive treatment using a flexible bracelet of magnetic beads may bring relief with fewer side effects than traditional surgery
07/23/2012: Aspirin protects against Barrett's esophagus
Aspirin use appears to reduce the risk of Barrett's esophagus, the largest known risk factor for esophageal cancer.
Massachusetts General Hospital introduces an innovative procedure for patients experiencing symptoms of GERD. A bracelet of magnetic beads can help the lower esophageal sphincter to resist gastric pressures and prevent reflux.
07/17/2012: Massachusetts General Hospital Ranked #1 in the Nation on U.S. News & World Report Honor Roll
Massachusetts General Hospital has moved into the number one spot on the 2012-13 U.S. News & World Report’s “America’s Best Hospitals” list.
07/16/2012: New Radiology and Endoscopy Techniques Are Improving Treatment of Pancreatic and Biliary Disorders
Patients seeking care for pancreatic and biliary system disorders at Massachusetts General Hospital’s Digestive Healthcare Center receive the latest in diagnostic and therapeutic treatments from a collaborative team of experts, including gastroenterologists, interventional endoscopists, pathologists, medical oncologists, surgeons, radiation oncologists, and radiation therapists.
Massachusetts General Hospital surgeon Matthew Hutter, MD, explains how a quality consortium of Partners HealthCare hospitals reduced colon surgery infections by 23%.
A recent study by the Centers for Disease Control and Prevention projects that three out of four obese children will become obese adults, increasing the obese adult population to 42 percent by 2030. Just days after the report, on May 10, the MGH Weight Center brought together clinicians from 24 different programs – many within MassGeneral Hospital for Children (MGHfC) – for the first Pediatric Obesity Collaborative Retreat.
Liver specialists at the Massachusetts General Hospital Digestive Healthcare Center have been studying the tenacious nature of HCV and exploring new approaches for treating this chronic infection. (From Advances Fall 2011 issue.)
02/14/2011: Surgeons Pioneer Sphincter-Sparing Treatment for Rectal Cancer—Helping Reduce Recurrence Rates
Advances Spring 2011 Issue. While sphincter-sparing surgery is fairly common for upper rectal and mid-rectal cancers, it is less common for low rectal cancers, which are more difficult to resect due to anatomical challenges and their proximity to important structures in the pelvis.
07/16/2010: MGH ranks among top
The MGH ranked third among the country's top hospitals on the annual list of "America's Best Hospitals" issue of U.S. News & World Report.
Up until the mid-1990s, physicians knew little about the relationship between pancreatic cysts and pancreatic cancer. But collaborative research conducted by gastroenterologists, surgeons, radiologists, and pathologists at the Massachusetts General Hospital Digestive Healthcare Center has led to a much greater understanding of pancreatic cystadenomas and what makes some cysts progress to cancer. These advances are opening up new therapies to target this deadly cancer early on, when it is most treatable.
03/31/2010: Colorectal Screening Saves Lives
Colorectal cancer is the third leading cause of cancer death among men and women nationwide. But, if detected early colorectal cancer is treatable and beatable.
Physicians can help stem the rising incidence of gastroesophageal cancers by aggressively treating patients with gastroesophageal reflux (GERD) and Barrett's esophagus.
Mass General surgeon Patricia Sylla, travels to Barcelona to perform the first-ever rectal cancer surgery on a human using natural orifice surgery (NOTES).
Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death, report investigators from Massachusetts General Hospital, Dana-Farber Cancer Institute and Brigham and Women’s Hospital.
07/22/2009: Mass. General-based research center will investigate why immune system fails to control hepatitis C
A research consortium based at Massachusetts General Hospital has been awarded $15 million from the National Institute of Allergy and Infectious Diseases to investigate how the hepatitis C virus resists suppression and clearance by the immune system.
06/29/2009: Incision-free gallbladder surgery
On May 20 David Rattner, MD, chief of General Surgery at the Massachusetts General Hospital Digestive Healthcare Center, performed New England’s first natural orifice surgery - completely incision free.
Join Massachusetts General Hospital and MassGeneral for Children medical staff June 27 - 28 in casual, face-to-face discussions on a variety of topics addressing health concerns for people of every age.
Massachusetts General Hospital (MGH) researchers are investigating a new way to block reproduction of the hepatitis C virus – targeting not the virus itself but the human genes the virus exploits in its life cycle.
03/02/2009: Friendly bacteria: do they do what’s promised?
Potential benefits of good bacteria prompt researchers to take a closer look.
11/26/2008: Relief from GERD, once and for all
Finally, good news for patients who have chosen not to have surgery to treat their gastroesophageal reflux disease (GERD) because they doubted surgery’s effectiveness. A new study reveals the benefits of a simple procedure that can vastly improve their quality of life. And, even better, the relief offered by this surgery is lasting and doesn’t require the hassle and expense of taking proton pump inhibitors (PPIs) and other prescription and over-the-counter drugs.
10/22/2008: Surgery without scalpels?
It may sound like science fiction, but the possibility of surgery that can be completed without a scar may soon be a reality.
The third oldest general hospital in the United States and the oldest and largest hospital in New England, Mass General continues its tradition of excellence today. The hospital is consistently ranked among the top five hospitals in the nation by U.S. News & World Report. In 2008, Mass General was redesignated a Magnet hospital, the highest honor for nursing excellence awarded by the American Nurses Credentialing Center.
Aspirin therapy's ability to reduce the risk of colorectal cancer, an association seen in a large number of studies, appears to depend on the drug's inhibition of the COX-2 enzyme, the action that also underlies aspirin's usefulness for treating pain and inflammation.
07/10/2013: Liver Center News
Managing an Emerging Epidemic: Nonalcoholic Fatty Liver Disease
In this issue of the Massachusetts General Hospital Liver Center e-newsletter, clinicians discuss management of nonalcoholic fatty liver disease, the leading cause of liver disease in the United States.
Sign up to receive Liver Center News
12/06/2012: Liver Center News
A New Era of Hepatitis C Therapy
Liver Center News, the Massachusetts General Hospital Liver Center e-newsletter, is produced by liver specialists for their clinical peers who treat patients with liver disease.
02/01/2012: Advances in Cancer
Advances in Cancer: Winter 2012 edition
Advances in Cancer: Winter 2012 edition
01/01/2011: Advances at Mass General
Advances at Mass General, summer 2012 issue
Read Advances at Mass General, a bi-annual news magazine published for our colleagues from the physicians of Massachusetts General Hospital.
01/01/2011: Mass General Magazine
Read more at www.massgeneralmag.org
Mass General Magazine is a publication for supporters and friends of Massachusetts General Hospital that takes you inside the hospital and explores its patient care and research programs here and around the world. It features rich photo essays and in-depth profiles from across the Mass General world.
David Ryan, MD, explains the reasons for the current epidemic of esophageal cancer.
David Rattner, MD, explains the management of gastroesophageal reflux, including indications for medical, endoscopy and surgical interventions to control this condition.
Christopher Morse, MD, reviews minimally invasive treatments for esophageal cancer, including esophageal resections. Please note that this video contains images from a real procedure and may cause discomfort for some viewers.
Vijay Yajnik, MD, gastroenterologist at the Massachusetts General Hospital Digestive Healthcare Center, explains why inflammatory bowel disease often goes untreated and the promising new therapies that can minimize IBD's impact on daily life.
David Rattner, MD, Co-Chief of the Massachusetts General Hospital Digestive Healthcare Center describes how chronic heartburn can lead to other serious conditions, who is most at risk and how Barrett's esophagus and esophageal cancer can be diagnosed and treated.
Liliana G. Bordeianou, MD, describes what causes incontinence in maturing women and treatment options
Liliana G. Bordeianou, MD, a colorectal surgeon at the Massachusetts General Hospital Digestive Healthcare Center says incontinence is not just a normal part of getting older and explains the treatments that can dramatically improve your quality of life.
Milena Weinstein, MD, urogynecologist at the Mass General Department of Obstetrics and Gynecology says urinary incontinence or vaginal bulge can be related to pelvic floor disorders, which affect one out of three women. Learn more about the treatments available for pelvic floor disorders, from exercise to support devices to surgery.
The Campaign for the Third Century of MGH Medicine kicked off Oct. 15 at the Westin Waterfront Boston. Nearly 500 of Mass General’s closest friends and supporters gathered to celebrate the public launch of the fundraising campaign that aims to raise $1.5 billion for the hospital. Already, $1 billion of that amount has been raised.
As a burn and critical care fellow at Mass General, Jonathan has worked closely with MGHfC staff. Why is he running to raise money for pediatric cancer care and research? “None of these kids asked for this problem, and neither did their families."
U.S. News & World Report ranks Mass General #2 in the nation and #1 in New England based on our quality of care, patient safety and reputation in 16 clinical specialties.
When you support the Digestive Healthcare Center, you are making a significant contribution to advancing care at the hospital.
Read and sign up to receive the Mass General Liver Center e-newsletter for clinicians who treat patients with liver disease.